Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling
Hong Ren(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 77
Related Papers
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial
|Journal of Clinical Oncology|2022|100
Clinical nephrology - IgA nephropathy, lupus nephritis, vasculitis
|Nephrology Dialysis Transplantation|2013|3